Schedule 13D ownership disclosure

MATINAS BIOPHARMA HLDGS INC

Security class unavailable · CUSIP: 576810105

Event date: 2017-03-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,396,760
Percent of class
24.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-17-000311
Form type
SC 13D
Filer
Lorenzo Jennifer
CIK
CIK 1697285
Filed
Mar 22, 2017
Reporting period
Mar 15, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub